Lidocaine Hydrochloride Market - Forecast(2024 - 2030)
Lidocaine Hydrochloride Market Overview
Lidocaine Hydrochloride Market Report Coverage:
The report: “Lidocaine Hydrochloride Market Forecast (2022-2027)”,
by Industry ARC, covers an in-depth analysis of the following segments of the Lidocaine
Hydrochloride Market.
By Form: Topical and Injectables.
By Application: Uneven Heart Beating,
Mucous Membrane Hitches, Cancer, Dental Operations, Skin Scratches, Other
Surgeries, and Operations.
By Distribution Channel: Hospital, Ambulatory
Surgical Centers, Retail Pharmacies, and Others.
By Geography: North America (U.S., Canada, and
Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of
Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New
Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest
of South America) and Rest of World (the Middle East and Africa).
Key Takeaways:
- Geographically, the North America Lidocaine Hydrochloride Market accounted for the highest revenue share in 2021. However, Asia-Pacific is poised to dominate the market over the period 2022-2027 owing to the rise in acute and chronic illnesses ascribing to elevating the old-age population.
- The heightening prevalence of cancer cases and dental hitches is driving the Lidocaine Hydrochloride Market report. However, several side effects allied with Lidocaine are one of the major factors that are said to reduce the growth of the Lidocaine Hydrochloride Market.
- Detailed analysis on the Strength,
Weaknesses, and Opportunities of the prominent players operating in the market
will be provided in the Lidocaine Hydrochloride Market report.
Lidocaine Hydrochloride Market- Geography (%)
Lidocaine Hydrochloride Market Segment Analysis-By Application
The Lidocaine Hydrochloride Market
based on the application type can be further segmented into uneven heart
beating (=Stokes-Adams Syndrome), mucous membrane hitches, chemotherapy, Dental
Operations, Skin scratches, other surgeries, and operations. The dental
operations segment held the largest share in 2021 owing to the factors such as
across the board use of Xylocaine in dental procedures such as surgeries.
Moreover, the Cancer segment is
estimated to be the fastest growing with a CAGR of 10.8% over the forecast period
2022-2027. It is owing to the surge in the number of cancer patients around the
globe, and the rising clinical research pertaining to the use of lidocaine in relieving
numbness, tingling, and other symptoms of neuropathy. In 2020, an estimated 1.9
million cancer cases were diagnosed in the USA. Similarly, other regions have
been proliferating growing.
Lidocaine Hydrochloride Market Segment Analysis-By Distribution Channel
The Lidocaine Hydrochloride Market
based on the Distribution Channel Type can be further segmented into hospitals,
Health Centers, Retail pharmacies, and others. The hospital pharmacy segment
held the largest share owing to the factors such as widescale use in various
operation procedures by doctors, the prevalence of a variety of cancer
sicknesses stimulating the necessity of procedures such as insertion of
catheters in patient’s body.
However, the Retail Pharmacies
segment is estimated to be the fastest-growing segment with a CAGR of 10.9%
over the period 2022-2027. Independent pharmacies have been growing in numbers,
as in the last decade within the US, around 12% registered within the following
segment. It is owing to the rising influence of government and private bodies
to provide finance and other facilities which ultimately result in growth.
Lidocaine Hydrochloride Market Segment Analysis-By Geography
The Lidocaine Hydrochloride based
on Geography can be further segmented into North America, Europe, Asia-Pacific,
South America, and the Rest of the World. North America held the largest share
with 35% of the overall market in 2021. The growth in this segment is owing to
the factors such as enlarging rates of acute and chronic maladies, several
dental complications ascribing to increasing trends of confectioneries among the
general American public especially children, broadening prevalence of cancer
and seizure disorders.
However, Asia-Pacific is estimated to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to proliferating old-age population across the Asian continent which is intensifying the occurrence of ailments such as the improper beating of the heart, cancer, and urethritis. On the other hand, the GDPs of Asian nations are prospering which ultimately ensuing more financing from the government into research and development. The share of the population aged 65 years and over is expected to increase by nearly two and half times in lower-middle- and low-income Asia-Pacific countries in the next decades to reach.
Lidocaine Hydrochloride Market Drivers
Augmenting sicknesses is Projected to Drive Market Growth.
Trends of using local anesthetics such as lidocaine have elevated in recent years with augmentation in acute and chronic health abnormalities. Also, the pervasiveness of cancer and deaths attributed to cancer are elevating. According to a WHO study around 1/4th to 1/5th deaths from cancer ascribing to smoking, alcohol and drugs intake, poor working out habits especially, In the North American continent. In 2021 around 1.8 to 1.9 million cases of cancer are anticipated to prevail in the US. Besides that, approximately 300 thousand ductal carcinomas were found in the US in starting months of the year 2021.
Elevating government spending on research and development is Expected to Boost Product Demand.
As the existence of health
complications is broadening healthcare sector is on the top of the governments'
priority list. Governments have proliferated the activities of refining their
respective country’s healthcare infrastructure. Developing countries are
allocating a glut of funds to research and development activities. India raised
its total healthcare spending by 137% in 2021. US healthcare spending is
assessed to cross the $6 trillion in foreseeable future. On the other hand,
heightening contributions to international health organizations such as WHO are
stimulating additional efforts into the research field.
Lidocaine Hydrochloride Market Challenges
Health side effects attributed to Lidocaine are Anticipated to Hamper Market Growth.
Even though the demand for
anesthetic is shooting up but one factor which is anticipated to strangle the
growth of the Lidocaine Hydrochloride Market is many side effects associated
with the use of lidocaine as an anesthetic. Hypotension, Nausea (= abrupt
impulse to vomit), Tenderness, giddiness, acute dementia, seizures, and
arrhythmia are several aftereffects of lidocaine. In addition to that, an
overdose of lidocaine can set serious cardiac arrests such as stoppage of
breathing, and comma in motion.
Lidocaine Hydrochloride Industry Outlook
Product launches, mergers and
acquisitions, joint ventures, and geographical expansions are key strategies
adopted by players in this market. Lidocaine Hydrochloride top 10 companies include:
- Perkin
- Pfizer
- SCILEX Pharmaceuticals, Inc.
- PENTAX medical
- Endomed system
- Nortec Qumica
- Hisamitsu Pharmaceutical
- KARL STORZ
- Cirondrugs
- Merck KGaA
Recent Developments
- October 13, 2021, Generic topical and injectable manufacturer “Teligent Pharma” recalled a lot of its topical lidocaine hydrochloride 4% containing many anesthetic agents ascribing to excessive potency because it might lead to an overdose of the drug and can set several health complications in motion. This isn’t the first manufacturing-related snafu Teligent has faced in recent years. The recall notice comes nearly two years after federal regulators reprimanded the specialty generic pharmaceutical company for taking its skin med to market despite multiple failed out of stability tests.
Relevant Links:
Anaesthesia Machines Market –
Forecast (2022 - 2027)
Report Code: HCR 0118
Sufentanil Citrate Market –
Forecast (2022 - 2027)
Report Code: HCR 0387
For more Lifesciences and Healthcare related reports, please click here
LIST OF TABLES
1.Global Global Lidocaine Hydrochloride Market, By Dosage Form Market 2023-2030 ($M)1.1 Cream Market 2023-2030 ($M) - Global Industry Research
1.2 Injectables Market 2023-2030 ($M) - Global Industry Research
2.Global Global Lidocaine Hydrochloride Market, By Dosage Form Market 2023-2030 (Volume/Units)
2.1 Cream Market 2023-2030 (Volume/Units) - Global Industry Research
2.2 Injectables Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America Global Lidocaine Hydrochloride Market, By Dosage Form Market 2023-2030 ($M)
3.1 Cream Market 2023-2030 ($M) - Regional Industry Research
3.2 Injectables Market 2023-2030 ($M) - Regional Industry Research
4.South America Global Lidocaine Hydrochloride Market, By Dosage Form Market 2023-2030 ($M)
4.1 Cream Market 2023-2030 ($M) - Regional Industry Research
4.2 Injectables Market 2023-2030 ($M) - Regional Industry Research
5.Europe Global Lidocaine Hydrochloride Market, By Dosage Form Market 2023-2030 ($M)
5.1 Cream Market 2023-2030 ($M) - Regional Industry Research
5.2 Injectables Market 2023-2030 ($M) - Regional Industry Research
6.APAC Global Lidocaine Hydrochloride Market, By Dosage Form Market 2023-2030 ($M)
6.1 Cream Market 2023-2030 ($M) - Regional Industry Research
6.2 Injectables Market 2023-2030 ($M) - Regional Industry Research
7.MENA Global Lidocaine Hydrochloride Market, By Dosage Form Market 2023-2030 ($M)
7.1 Cream Market 2023-2030 ($M) - Regional Industry Research
7.2 Injectables Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)2.Canada Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
3.Mexico Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
4.Brazil Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
5.Argentina Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
6.Peru Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
7.Colombia Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
8.Chile Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
9.Rest of South America Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
10.UK Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
11.Germany Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
12.France Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
13.Italy Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
14.Spain Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
15.Rest of Europe Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
16.China Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
17.India Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
18.Japan Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
19.South Korea Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
20.South Africa Lidocaine Hydrochloride Market Revenue, 2023-2030 ($M)
21.North America Lidocaine Hydrochloride By Application
22.South America Lidocaine Hydrochloride By Application
23.Europe Lidocaine Hydrochloride By Application
24.APAC Lidocaine Hydrochloride By Application
25.MENA Lidocaine Hydrochloride By Application
26.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Sigma-Aldrich Co Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Mahendra Chemical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Alanza Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Ciron Drug Pharmaceutical Pvt Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Pr; Venture, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Medexim India, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Zuche Pharmaceutical Pvt. Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Amphastar Pharmaceuticals, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Nortec Qumica, Sales /Revenue, 2015-2018 ($Mn/$Bn)